Campbell & Co Investment Adviser’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Campbell & Co Investment Adviser's LLY Position: Q1 2026 in Review
Campbell & Co Investment Adviser increased its Eli Lilly (LLY) stake by 139% in Q1 2026, buying an estimated $4.15M and bringing the position to 7,041 shares worth $6.47M. The position accounts for 0.37% of the portfolio, ranked #42.
Campbell & Co Investment Adviser first reported a position in LLY in Q2 2013 and has held it in 15 quarters since. The position peaked at $9.3M in Q2 2013. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Campbell & Co Investment Adviser held 7,041 shares of Eli Lilly worth $6.47M as of Q1 2026.
- Campbell & Co Investment Adviser bought 4,091 Eli Lilly shares in Q1 2026, an estimated $4.15M.
- Eli Lilly made up 0.37% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #42 holding.
- Campbell & Co Investment Adviser first reported a position in Eli Lilly in Q2 2013 and has held it in 15 quarters since.
- Campbell & Co Investment Adviser's Eli Lilly position peaked at $9.3M in Q2 2013.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.